Elevation Oncology, Inc. ( ($ELEV) ) has released its Q4 earnings. Here is a breakdown of the information Elevation Oncology, Inc. presented to ...

Elevation' hit theaters in November 2024 as a post-apocalyptic action thriller where apex predators have forced Earth's inhabitants into small, pocketed communities that exist thousands of feet ...

In December 2024, Elevation Oncology nominated EO-1022 as its HER3 ADC development candidate for the treatment of HER3-expressing solid tumors including breast cancer and non-small cell lung cancer.

GMC Terrain deals again include up to $3,000 off, plus low-interest financing with no payments till next year, special lease ...

In December 2024, Elevation Oncology presented preclinical proof-of-concept data supporting the combination potential of EO-3021 with VEGFR2 or PD-1 inhibitors at the ESMO Immuno-Oncology Annual ...